Biochemistry Analyzers Market Report 2025

This biochemistry analyzers market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The biochemistry analyzers market size has grown strongly in recent years. It will grow from $4.5 billion in 2024 to $4.82 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to rising healthcare expenditure, focus on early disease detection, increased research and development, rising awareness of preventive healthcare, and government health initiatives.

The biochemistry analyzers market size is expected to see strong growth in the next few years. It will grow to $6.27 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increased automation in laboratories, advancements in molecular diagnostics, expansion of biotech, development of point-of-care testing, and growth in personalized medicine. Major trends in the forecast period include integration with artificial intelligence, miniaturization and portability, enhanced multimodal capabilities, sustainability and eco-friendly products, and expansion of reagent and consumable markets.

The growing prevalence of chronic disorders is expected to drive the expansion of the biochemistry analyzers market in the future. Chronic disorders are long-term health conditions that require ongoing management and care. The rise in these disorders is largely due to aging populations, lifestyle changes, and increasing risk factors such as poor diet, physical inactivity, and pollution. Biochemistry analyzers play a crucial role in managing chronic disorders by measuring and monitoring biomarkers for diagnosis, disease progression, and treatment effectiveness. For example, a report from the American College of Cardiology published in August 2022 projects that major cardiovascular risk factors in the U.S. will increase significantly from 2025 to 2060. Diabetes is expected to see the largest rise, with a 39.3% increase to 55 million individuals, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). Consequently, the growing number of chronic disorders is driving the growth of the biochemistry analyzers market.

Leading companies in the biochemistry analyzers market are focusing on developing innovative solutions, such as advanced chemistry analyzers, to enhance productivity, efficiency, and reliability in medium-volume laboratories. A chemistry analyzer is a diagnostic tool used to measure and analyze chemical components in biological samples such as blood or urine for health assessment and disease diagnosis. For instance, in May 2022, Mindray Bio-Medical Electronics Co., Ltd., a China-based medical devices company, introduced the BS-600M Chemistry Analyzer. This device is designed to improve the productivity and efficiency of medium-volume laboratories, featuring a compact footprint of just 1.2 square meters while achieving a throughput of 600 tests per hour, which can be increased to 800 tests per hour with the integrated Ion Selective Electrode (ISE) module. This high throughput per square meter makes it a leading choice for labs aiming to maximize space and efficiency.

In December 2023, Mindray Medical International Limited, a medical device company based in China, acquired DiaSys Diagnostic Systems GmbH for $126 million. This acquisition will enable Mindray's IVD business to utilize DiaSys' expertise and global supply platforms, enhancing its overseas supply chain and allowing for expansion into medium- to large customer segments. DiaSys Diagnostic Systems GmbH is a manufacturing company located in Germany that specializes in the development, production, and marketing of biochemistry analyzers.

Major companies operating in the biochemistry analyzers market are Roche Diagnostics AG, Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Becton Dickinson and Company, Medline Industries LP, Tosoh Corporation, Agilent Technologies Inc, bioMérieux SA, QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc, Qiagen NV, Werfen Group SA, DiaSorin SpA, Bio-Techne Corporation, Meril Life Sciences Private Limited, Randox Laboratories Ltd, Getein Biotech Inc, Aesku Diagnostics GmbH & Co KG, Carolina Liquid Chemistries Corporation, Arlington Scientific Inc, Chengdu Seamaty Technology Co Ltd, Hipro Biotechnology Co Ltd.

North America was the largest region in the biochemistry analyzers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biochemistry analyzers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biochemistry analyzers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Biochemistry analyzers are laboratory instruments designed to measure the concentration of various biochemical substances in biological samples such as blood, urine, serum, plasma, and cerebrospinal fluid. These analyzers are essential in clinical diagnostics, as they help analyze chemical reactions and properties related to metabolism, organ function, and the detection of specific diseases.

The primary types of biochemistry analyzers are semi-automated and fully automated. A semi-automated biochemistry analyzer requires some manual intervention, such as loading samples and reagents, but automates critical processes such as measurement and data analysis. These devices come in benchtop and floor-standing models and are used in applications such as clinical diagnostics, bioreactor byproduct detection, and drug development. They serve various users, including hospitals, diagnostic centers, pharmaceutical and biotechnology companies, academic research institutions, and contract research organizations.

The biochemistry analyzers market research report is one of a series of new reports that provides biochemistry analyzers market statistics, including biochemistry analyzers industry global market size, regional shares, competitors with a biochemistry analyzers market share, detailed biochemistry analyzers market segments, market trends and opportunities, and any further data you may need to thrive in the biochemistry analyzers industry. This biochemistry analyzers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biochemistry analyzers market consists of sales of dry chemistry analyzers, wet chemistry analyzers, ion-selective electrode (ISE) biochemistry analyzers, random access analyzers, dedicated biochemistry analyzers, and continuous flow biochemistry analyzers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.